Nectar Lifesciences Limited is a pharmaceutical company that manufactures and markets pharmaceutical products in India and globally. The company specializes in producing active pharmaceutical ingredients and intermediates, including cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine. Additionally, Nectar Lifesciences Limited offers contract manufacturing services for various finished dosage forms, such as tablets, capsules, dry powder oral suspensions, granules, and injectables for cephalosporins. The company also supplies menthol and mint derivatives, as well as empty hard gelatin capsules. Established in 1995, Nectar Lifesciences Limited is headquartered in Chandigarh, India.
Navigation section
Nectar Lifesciences Limited
- 34.00 -0.87(-2.49%) 34.77 -0.03(-0.09%)
Performance
| Today's Low | Today's High | |
|---|---|---|
| 33.12 33.06 | 36.44 36.45 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 26.15 (04-Jun-2024) 26.20 (04-Jun-2024) | 56.50 (11-Sep-2024) 56.39 (11-Sep-2024) |
- Open
- 35.20 34.80
- Previous Close
- 34.87 34.80
- Volume
- 141.54
- Total Traded value
- 47.46 (₹ Lakhs)
- Upper circuit
- 36.61 40.52
- Lower circuit
- 33.12 27.02
Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 137,573 | 0 |
| Bid Price | Quantity |
|---|---|
| 33.47 | 137,573.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | 137,573 |
| Ask Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
Fundamentals
| Market Cap: | ₹7.62 Cr |
| PE Ratio (TTM): | 72.71 |
| PB Ratio: | 0.73 |
| Industry P/E: | 72.90 |
| Debt to Equity: | - |
| ROE: | 1.00 |
| EPS (TTM): | 0.48 |
| Book Value: | 45.33 |
| Face Value: | 1.00 |
Financials
| Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | |
|---|---|---|---|---|---|
| Revenue | 397.96 Cr | 394.12 Cr | 388.81 Cr | 344.13 Cr | 388.65 Cr |
| Profit | 1.02 Cr | 1.82 Cr | 5.36 Cr | -9.29 Cr | -22.47 Cr |
| Expense | 406.93 Cr | 391.54 Cr | 403.55 Cr | 374.93 Cr | 431.83 Cr |
| Comprehensive income | 1.02 Cr | 1.82 Cr | 5.55 Cr | -9.29 Cr | -22.47 Cr |
| EPS | 0.05 | 0.08 | 0.24 | -0.41 | -1.00 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Nectar Lifesciences Limited | Jul, 2005 Jul, 2005 | Pharmaceuticals Pharmaceuticals | NECLIFE NECLIFE |
Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
Nectar Lifesciences Limited FAQ's
What is the range of today's stock performance for Nectar Lifesciences Limited?
Today's stock performance witnessed a fluctuation from a minimum of 33.12 on the NSE (National Stock Exchange) to a maximum of 36.44. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 33.06 to a high of 36.45.
What are the 52-week low and high values for Nectar Lifesciences Limited?
The stock's performance over the past 52 weeks reveals a low of 26.15 (occurred on 04-Jun-2024) and a high of 56.50 (achieved on 11-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 26.20 (on 04-Jun-2024), and the 52-week high is 56.39 (on 11-Sep-2024).
What was the opening and previous closing prices for Nectar Lifesciences Limited?
The stock's performance over the past 52 weeks reveals a low of 26.15 (occurred on 04-Jun-2024) and a high of 56.50 (achieved on 11-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 26.20 (on 04-Jun-2024), and the 52-week high is 56.39 (on 11-Sep-2024).
What is the total volume and traded value for Nectar Lifesciences Limited for the day?
The total volume is 142, and the total traded value is 47.46 (₹ Lakhs).
What are the upper and lower circuit limits for Nectar Lifesciences Limited?
The upper circuit limit is 36.61, and the lower circuit limit is 33.12.
What is the market cap and PE ratio for Nectar Lifesciences Limited?
The market cap is ₹7.62 Cr, and the PE ratio (TTM) is 72.90.
What is the PB ratio, industry P/E, and debt to equity ratio for Nectar Lifesciences Limited?
The PB ratio is 0.75, industry P/E is 72.90 .
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Nectar Lifesciences Limited?
ROE is 1.00, EPS is 0.48, book value is 45.33
What are the revenue and profit figures for the latest quarter and previous quarters for Nectar Lifesciences Limited?
In Sep 2023, Revenue is ₹3979633000.00, and Profit is ₹10153000.00. In Jun 2023, Revenue is ₹3941226000.00, and Profit is ₹18204000.00.
When was Nectar Lifesciences Limited listed, and what industry does it belong to?
The company, Nectar Lifesciences Limited, was listed in Jul 2005 and belongs to the Pharmaceuticals industry. Its NSE symbol is NECLIFE.
What is the current shareholding pattern of the Nectar Lifesciences Limited?
As of latest available update, promoters hold 55.80%, the public holds 44.20%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 29
- Threads
- 96
